Pages that link to "Q37265745"
Jump to navigation
Jump to search
The following pages link to Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. (Q37265745):
Displaying 50 items.
- Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions (Q24198236) (← links)
- Major clinical research advances in gynecologic cancer in 2013 (Q24562146) (← links)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer (Q24607403) (← links)
- American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. (Q26828840) (← links)
- New strategies for human papillomavirus-based cervical screening (Q26851699) (← links)
- Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts (Q27023127) (← links)
- New paradigms in cervical cancer prevention: opportunities and risks (Q33394011) (← links)
- BMI-1 autoantibody as a new potential biomarker for cervical carcinoma (Q34087890) (← links)
- Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature (Q34173407) (← links)
- Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test (Q34250191) (← links)
- MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA. (Q34289092) (← links)
- Triage of HPV-positive women in cervical cancer screening (Q34344762) (← links)
- The history and future of targeting cyclin-dependent kinases in cancer therapy (Q34460347) (← links)
- Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population (Q34543338) (← links)
- Prognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study (Q34608714) (← links)
- Human Papillomavirus Testing in the Prevention of Cervical Cancer (Q34616083) (← links)
- Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice (Q34850316) (← links)
- hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy (Q34979227) (← links)
- Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial (Q35117225) (← links)
- Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test (Q35140046) (← links)
- Clinical Implication of p16, Ki-67, and Proliferating Cell Nuclear Antigen Expression in Cervical Neoplasia: Improvement of Diagnostic Accuracy for High-grade Squamous Intraepithelial Lesion and Prediction of Resection Margin Involvement on Conizati (Q35261428) (← links)
- The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections. (Q35619352) (← links)
- Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice (Q35738881) (← links)
- Evaluation of The Cervista HPV A9 group In Screening Patients for Cervical Cancer (Q35807133) (← links)
- Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs (Q35864909) (← links)
- HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice (Q36071760) (← links)
- Roles of Foxp3 in the occurrence and development of cervical cancer (Q36095042) (← links)
- High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology (Q36118590) (← links)
- Claspin as a biomarker of human papillomavirus-related high grade lesions of uterine cervix (Q36207038) (← links)
- Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature (Q36298250) (← links)
- Laboratory and clinical aspects of human papillomavirus testing (Q36311573) (← links)
- Optimizing technology for cervical cancer screening in high-resource settings (Q36319941) (← links)
- p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women (Q36361863) (← links)
- Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. (Q36668105) (← links)
- Triage of HPV positive women in cervical cancer screening (Q36679896) (← links)
- Primary extraosseous Ewing sarcoma of the lung in children (Q36791086) (← links)
- Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention (Q37066141) (← links)
- Characterization of p16 and E6 HPV-related proteins in uterine cervix high-grade lesions of patients treated by conization with large loop excision (Q37093527) (← links)
- The evolving definition of carcinogenic human papillomavirus (Q37202940) (← links)
- Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology (Q37204870) (← links)
- Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study (Q37271280) (← links)
- Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate (Q37294687) (← links)
- Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting (Q37355500) (← links)
- How to evaluate emerging technologies in cervical cancer screening? (Q37467429) (← links)
- History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results (Q37570873) (← links)
- Cervical intraepithelial neoplasia in pregnancy: Interference of pregnancy status with p16 and Ki-67 protein expression (Q37593939) (← links)
- Primary and secondary prevention of cervical cancer (Q37628689) (← links)
- The road ahead for cervical cancer prevention and control (Q37719631) (← links)
- The Presence of Human Papillomavirus or p16 in Six Cases of Retroperitoneal Carcinoma (Q37802146) (← links)
- Eurogin 2010 roadmap on cervical cancer prevention (Q37826158) (← links)